Concepts Driving Pharmacogenomics Implementation Into Everyday Healthcare

by Giri J, Moyer AM, Bielinski SJ, Caraballo PJ
Published 2019-10-01

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]

by Takahashi PY, Ryu E, Cerhan JR, Bielinski SJ, Olson JE
Published 2021-05-01

No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study

by Takahashi PY, Ryu E, Bielinski SJ, Hathcock M, Jenkins GD, Cerhan JR, Olson JE
Published 2021-02-01

Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics

by Lopes GS, Bielinski SJ, Moyer AM, Black III JL, Jacobson DJ, Jiang R, Larson NB, St Sauver JL
Published 2020-03-01

Increased risk of hospitalization for ultrarapid metabolizers of cytochrome P450 2D6

by Takahashi PY, Ryu E, Pathak J, Jenkins GD, Batzler A, Hathcock MA, Black JL, Olson JE, Cerhan JR, Bielinski SJ
Published 2017-02-01

Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank

by Takahashi PY, Ryu E, Olson JE, Winkler EM, Hathcock MA, Gupta R, Sloan JA, Pathak J, Bielinski SJ, Cerhan JR
Published 2015-08-01

CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications

by St Sauver JL, Olson JE, Roger VL, Nicholson WT, Black III JL, Takahashi PY, Caraballo PJ, Bell EJ, Jacobson DJ, Larson NB, Bielinski SJ
Published 2017-07-01